News

A Roadmap to Cure CHD2-Related Disorders published in Therapeutic Advances in Rare Disease

The peer-reviewed paper, "A Roadmap to Cure CHD2-Related Disorders," by CCC's board and Scientific Advisory Board has been published in the journal, Therapeutic Advances in Rare Disease.

Prestigious New England Journal of Medicine Publishes Study of CHD2-Adjacent Gene, CHASERR

Board Co-President Brian Broadbent has worked tirelessly to find treatment for his daughter Emma, who has a change in the CHASERR gene, which causes her to have too much, instead of too little, CHD2, with profound impact. A study of Emma was recently published.